ArticleAnnals of hematology2019

Prolonged severe neutropenia after the first daratumumab administration for multiple myeloma with baseline neutropenia.

Fumihiko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.